Liquidia Corp (LQDA)
About Liquidia Corp
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $158.3M
- Net income
- -$68.9M
- Total assets
- $327.9M
- Market cap
- $7.7B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $7.7B
- Shares outstanding
- 175.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 26, 2018
Liquidia Corp (LQDA) Stock Price
- Reported a net loss of $68.9M in FY2025.
- Trading 52% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Liquidia Corp.
Write a review
News about Liquidia Corp
News & sentiment via Polygon.io
Liquidia Corp: frequently asked questions
Is Liquidia Corp an American company?
Liquidia Corp is a US-based company headquartered in Morrisville, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Liquidia Corp headquartered?
Liquidia Corp is headquartered in Morrisville, North Carolina, United States.
Is Liquidia Corp publicly traded?
Yes — Liquidia Corp is a publicly traded company. Its stock trades under the ticker symbol LQDA on the NASDAQ.
What does Liquidia Corp do?
Liquidia Corp is an American Pharmaceuticals company in the Health & Beauty sector.
